Jade Biosciences (JBIO) Capital Expenditures (2021 - 2025)

Jade Biosciences has reported Capital Expenditures for 4 years, with the latest figure at $3000.0 in Q4 2025.

• For the quarter ending Q4 2025, Capital Expenditures changed N/A year-over-year to $3000.0; the trailing twelve-month figure through Dec 2025 stood at $196000.0 (changed N/A YoY), and the FY2025 full-year result was $196000.0, changed N/A from the prior year.
• Capital Expenditures for Q4 2025 stood at $3000.0, down from $177000.0 in the prior quarter.
• The five-year high for Capital Expenditures was $177000.0 in Q3 2025, with the low at -$124000.0 in Q3 2022.
• Historically, Capital Expenditures has averaged $47600.0 across 4 years, with a median of $30000.0 in 2023.
• Annual changes were most pronounced in 2022 — Capital Expenditures plunged 1966.67% — and 2023, when it jumped 114.52%.
• Jade Biosciences' Capital Expenditures stood at $147000.0 in 2021, then climbed by 9.52% to $161000.0 in 2022, then sank by 51.55% to $78000.0 in 2023, then sank by 96.15% to $3000.0 in 2025.
• The last three Capital Expenditures figures came in at $3000.0 (Q4 2025), $177000.0 (Q3 2025), and $11000.0 (Q2 2025), per Business Quant data.